Αρχειοθήκη ιστολογίου

Παρασκευή 19 Ιανουαρίου 2018

Personalized chemosensitivity assays for mesothelioma- is it worth the effort?

Cell-lines formed from an individual's tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of current therapeutic paradigms, such assays could be used to treat patients with the most effective agents specific to their "chemical profile".



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2rjOBBW

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου